Skip to main content Skip to main content
Go to homepage

Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Risk-Based Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)


For complete study information, please visit

Study Status:
IRB Study ID:
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email
Lead Investigator
Steven Kuerbitz, MD

Director, Divisional Research, Shannon E. Wilkes Targeted Therapy Program; The Jeffrey A. Barbour Chair for Pediatric Hematology Oncology Research and Healing; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program